PUBLICATIONS
Journal articles
add
Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Withers B; Hamad N, 2023, 'Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 366 - 372, http://dx.doi.org/10.6004/jnccn.2022.7255
2023
Blennerhassett R; Othman J; Biscoe A; Kliman D; Mills G; Blyth E; Micklethwaite K; Kwan J; Bilmon I; Bhattacharyya A; Panicker S; Fay K; Milliken S; Ma D; Hamad N; Stevenson W; Arthur C; Moore J; Greenwood M; Gottlieb D; Kerridge I, 2023, 'Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.16043
2023
Penglase R; Girgis L; Englert H; Brennan X; Jabbour A; Kotlyar E; Ma D; Moore J, 2023, 'Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis', Journal of Scleroderma and Related Disorders, http://dx.doi.org/10.1177/23971983221145639
2023
Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ, 2022, 'Sustained immunotolerance in multiple sclerosis after stem cell transplant', Annals of Clinical and Translational Neurology, 9, pp. 206 - 220, http://dx.doi.org/10.1002/acn3.51510
2022
Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.798300
2022
Brennan X; Withers B; Jabbour A; Milliken S; Kotlyar E; Fay K; Ma D; Muthiah K; Hamad N; Dodds A; Bart N; Keogh A; Hayward C; Macdonald P; Moore J, 2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926
2022
Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ, 2022, 'Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation', Frontiers in Immunology, 12, pp. 782935, http://dx.doi.org/10.3389/fimmu.2021.782935
2022
Achini-Gutzwiller FR; Snowden JA; Corbacioglu S; Greco R; Alexander T; Snowden J; Badoglio M; Labopin M; Abinun M; Apte S; Arnold R; Domenech A; Brierley C; Burman J; Castilla-Llorente C; Cooper N; Daghia G; Daikeler T; del Papa N; de Vries-Bouwstra J; Farge D; Finke J; Hagglund H; Hawkey C; Henes J; Hiepe F; Jessop H; Kiely D; Kazmi M; Kirgizov K; Kramer E; Mancardi G; Marjanovic Z; Martin R; Martin T; Ma D; Moore J; Miller P; Muraro P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Ricart E; Rovira M; Saccardi R; Saif M; Sakellari I; Sharrack B; Snarski E; Scherer HU; Sossa C; Withers B; Wulffraat N; Zaccara E; Amrolia P; Ansari M; Balduzzi A; Corbacioglu S; Dalassier A; Dalle JH; Diaz CH; Feuchtinger T; Locatelli F; Lucchini G; Galimard JE; Vincent MG; Handgretinger R; Kleinschmidt K; Lawitschka A; Martinez AP; Peters C; Rocha V; Ruggeri A; Sedlacek P; Svec P; Toporski J; Yesilipek A, 2022, 'Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation', British Journal of Haematology, 198, pp. 24 - 45, http://dx.doi.org/10.1111/bjh.18176
2022
Penglase R; Englert H; Tymms K; Carr A; Ma D; Milliken S; Moore J, 2022, 'Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning—do we need 200 mg/kg cyclophosphamide?', Bone Marrow Transplantation, 57, pp. 1207 - 1209, http://dx.doi.org/10.1038/s41409-022-01696-5
2022
Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072
2022
Nivison-Smith I; Bajel A; Dodds AJ; Gottlieb D; Hamad N; Kennedy G; Kerridge I; Ma DDF; Milliken S; Moore J; Purtill D; Szer J, 2022, 'Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience', Internal Medicine Journal, 52, pp. 57 - 62, http://dx.doi.org/10.1111/imj.15128
2022
Kliman D; Tran S; Kennedy G; Curley C; McLean A; Gottlieb D; Kwan J; Ritchie D; Chee L; Spencer A; Purtill D; Bardy P; Larsen S; Chien N; Perera T; Greenwood M; Hamad N; Moore J, 2022, 'The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR', Bone Marrow Transplantation, 57, pp. 982 - 989, http://dx.doi.org/10.1038/s41409-022-01683-w
2022
Hsu H; Seah V; Marriott D; Moore J, 2022, 'Enterococcus cecorum infective endocarditis in a patient with chronic myeloid leukaemia and cirrhosis', Pathology, 54, pp. 495 - 497, http://dx.doi.org/10.1016/j.pathol.2021.07.004
2022
McErlean G; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2022, 'Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey', Journal of Cancer Survivorship, 16, pp. 432 - 444, http://dx.doi.org/10.1007/s11764-021-01038-2
2022
McCaughan GJ; Gandolfi S; Moore JJ; Richardson PG, 2022, 'Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review', British Journal of Haematology, 199, pp. 190 - 204, http://dx.doi.org/10.1111/bjh.18295
2022
Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson A-M; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2021, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry', Blood, 138, pp. 2929 - 2929, http://dx.doi.org/10.1182/blood-2021-149939
2021
Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DDF; Moore JJ; Massey JC, 2021, 'Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis', Multiple Sclerosis Journal, 27, pp. 2112 - 2115, http://dx.doi.org/10.1177/13524585211005660
2021
Murray DD; Zaunders J; Milliken ST; Mee Ling Munier C; Ford C; Orla Morrissey C; Visweswaran M; Avery S; Sasadeusz J; Kwan J; Desai S; Law M; Koelsch KK; Lewin SR; Moore J; Kelleher AD; Polizzotto MN, 2021, 'Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients with Human Immunodeficiency Virus (HIV)', Clinical Infectious Diseases, 72, pp. 1141 - 1146, http://dx.doi.org/10.1093/cid/ciaa748
2021
Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-154028
2021
Kennedy GA; Tey SK; Buizen L; Varelias A; Gartlan KH; Curley C; Olver SD; Chang K; Butler JP; Misra A; Subramoniapillai E; Morton AJ; Durrant S; Henden AS; Moore J; Ritchie D; Gottlieb D; Cooney J; Paul SK; Hill GR, 2021, 'A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis', Blood, 137, pp. 1970 - 1979, http://dx.doi.org/10.1182/blood.2020009050
2021
Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2021, 'Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivors', Journal of Psychosocial Oncology, 39, pp. 534 - 552, http://dx.doi.org/10.1080/07347332.2020.1870644
2021
Mills G; Moore J; Cliff E; Fong CY; Mangalasseril S; Tiley C; Gilbertson M; Ku M; Bazargan A; Bryson M; Menzies Wojtowicz M; Sungala NP; Cunningham I; Tang C; Hamad N, 2021, 'Promising Real World Survival Data in Adult-Onset Langerhans Cell Histiocytosis: An Australasian Lymphoma Alliance 20 Year Retrospective Study', Blood, 138, pp. 2570 - 2570, http://dx.doi.org/10.1182/blood-2021-152131
2021
Perram J; Mayson E; Tang C; Tran S; Aarons D; Dodds AJ; Fay K; Hamad N; Ma D; Milliken S; Withers B; Greenwood M; Stevenson WS; Arthur CK; Kerridge IH; Moore J, 2021, 'Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-147106
2021
McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8
2021
McCaughan GJ; Verma A; Ling S; Lavee O; Moore JJ; Bryant A, 2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, 56, pp. 738 - 740, http://dx.doi.org/10.1038/s41409-020-01086-9
2021
Blennerhassett R; Moses JH; Coulits N; Horne A; Simpson J; Marshall J; Weston L; Moore J, 2021, 'Recurrent secondary graft failure likely due to a DRB4 donor-specific antibody in a patient with aplastic anemia and DRB4 null allele', Bone Marrow Transplantation, 56, pp. 2603 - 2605, http://dx.doi.org/10.1038/s41409-021-01402-x
2021
Cashman H; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S; Withers B; Lavee O; Milliken S; Moore J; Hamad N, 2021, 'Integrated electronic health record facilitates a safer and more efficient rural outreach haematology service', Internal Medicine Journal, 51, pp. 1869 - 1875, http://dx.doi.org/10.1111/imj.14973
2021
Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ, 2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, 26, pp. 1868 - 1875, http://dx.doi.org/10.1016/j.bbmt.2020.06.030
2020
Moore J; Kwan J; Gottlieb D; Bajel A; Ritchie D; Yeung DT; Greenwood M; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up', Blood, 136, pp. 51 - 52, http://dx.doi.org/10.1182/blood-2020-142131
2020
Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H, 2020, 'Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (Bone Marrow Transplantation, (2020), 55, 4, (681-694), 10.1038/s41409-019-0718-7)', Bone Marrow Transplantation, 55, pp. 838 - 839, http://dx.doi.org/10.1038/s41409-019-0740-9
2020
Hendrawan K; Visweswaran M; Ma DDF; Moore JJ, 2020, 'Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, 55, pp. 857 - 866, http://dx.doi.org/10.1038/s41409-019-0710-2
2020
Cashman H; Mayson E; Kliman D; Vachalec S; Bell J; Milliken S; Moore J; Lavee O; Withers B; Hamad N, 2020, 'A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic', Blood, 136, pp. 5 - 5, http://dx.doi.org/10.1182/blood-2020-142209
2020
McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', Blood, 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269
2020
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2020, 'Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial', The Lancet Haematology, 7, pp. e100 - e111, http://dx.doi.org/10.1016/S2352-3026(19)30220-0
2020
Brice L; McErlean G; Donovan C; Tapp C; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I, 2020, 'Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study', European Journal of Oncology Nursing, 49, http://dx.doi.org/10.1016/j.ejon.2020.101845
2020
Sharrack B; Saccardi R; Alexander T; Badoglio M; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro PA; Rovira M; Sormani MP; Snowden JA; McGrath E; Bambi F; Sanchez-Guijo F; Worel N; Badolglio M; Abinun M; Arnold R; Brierley C; Castilla-Llorente C; Cooper N; Daikeler T; del Papa N; Finke J; Reax R; Hagglund H; Henes J; Hiepe F; Kiely D; Mancardi G; Marjanovic Z; Martin T; Ma D; Moore J; Miller P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Saif M; Sakellari I; Snarski E; Scherer HU; Sossa C; de Vries-Bouwstra J; Wulffraat N; Zaccara E, 2020, 'Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)', Bone Marrow Transplantation, 55, pp. 283 - 306, http://dx.doi.org/10.1038/s41409-019-0684-0
2020
Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H, 2020, 'Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)', Bone Marrow Transplantation, 55, pp. 681 - 694, http://dx.doi.org/10.1038/s41409-019-0718-7
2020
Saccardi R; Badoglio M; Burman J; Helbig G; Kazmi MA; Mancardi G; Mielke S; Moore J; Muraro P; Sanz J; Sharrack B; Smilowski M; Sormani MP; Snowden JA, 2019, 'BEAM Vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society', Blood, 134, pp. 3313 - 3313, http://dx.doi.org/10.1182/blood-2019-125233
2019
McCarthy R-L; McNamee N; Copelin B; Mills G; Wong S; Qiu MR; Earls P; Milliken S; Hamad N; Fay K; Lukeis R; Parker A; Moore J, 2019, 'A case series of langerhans cell histiocytosis with braf testing', Pathology, 51, pp. S92 - S92, http://dx.doi.org/10.1016/j.pathol.2018.12.243
2019
Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF, 2019, 'Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 514 - 521, http://dx.doi.org/10.1136/jnnp-2018-319446
2019
Roy J; Panzarella T; Couban S; Couture F; Devins GM; Elemary M; Foley SR; Gallagher G; Kuruvilla J; Lee SJ; Moore J; Nevill TJ; Popradi G; Schultz KR; Szwajcer D; Toze CL; Walker I, 2019, 'Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial', Blood, 134, pp. 875 - 875, http://dx.doi.org/10.1182/blood-2019-123275
2019
Kennedy GA; Tey S-K; Curley C; Butler JP; Misra A; Subramoniapillai E; Morton J; Durrant S; Hendon AS; Moore J; Ritchie D; Gottlieb D; Cooney J; Buizen L; Paul SK; Hill GR, 2019, 'Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation', Blood, 134, pp. 368 - 368, http://dx.doi.org/10.1182/blood-2019-126285
2019
Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I, 2019, 'A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia', Transplant Infectious Disease, 21, http://dx.doi.org/10.1111/tid.13043
2019
Jessop H; Farge D; Saccardi R; Alexander T; Rovira M; Sharrack B; Greco R; Wulffraat N; Moore J; Kazmi M; Badoglio M; Adams G; Verhoeven B; Murray J; Snowden JA, 2019, 'General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)', Bone Marrow Transplantation, 54, pp. 933 - 942, http://dx.doi.org/10.1038/s41409-019-0430-7
2019
Ismail A; Sharrack B; Saccardi R; Moore JJ; Snowden JA, 2019, 'Autologous haematopoietic stem cell therapy for multiple sclerosis: A review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation', Current Opinion in Supportive and Palliative Care, 13, pp. 394 - 401, http://dx.doi.org/10.1097/SPC.0000000000000466
2019
Massey JC; Sutton IJ; Ma DDF; Moore JJ, 2018, 'Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant', Frontiers in Immunology, 9, http://dx.doi.org/10.3389/fimmu.2018.00410
2018
Abeysinghe P; Morawaka L; Gunasekara S; Suresh S; Udara PHSP; Siriwardena PPR; Milliken S; Ma DDF; Moore J, 2018, 'Working together: Establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri Lanka', Blood Advances, 2, pp. 46 - 49, http://dx.doi.org/10.1182/bloodadvances.2018GS110686
2018
Dyer G; Brice L; Schifter M; Gilroy N; Kabir M; Hertzberg M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Huang G; Hogg M; Brown L; Tan J; Ward C; Kerridge I, 2018, 'Oral health and dental morbidity in long-term allogeneic blood and marrow transplant survivors in Australia', Australian Dental Journal, 63, pp. 312 - 319, http://dx.doi.org/10.1111/adj.12627
2018
Dyer G; Brice L; Gilroy N; Kabir M; Hertzberg M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Huang G; Hogg M; Brown L; Tan J; Ward C; Kerridge I, 2018, 'Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia', Bone Marrow Transplantation, 53, pp. 926 - 931, http://dx.doi.org/10.1038/s41409-018-0098-4
2018
Lim ABM; Curley C; Fong CY; Bilmon I; Beligaswatte A; Purtill D; Getta B; Johnston AM; Armytage T; Collins M; Mason K; Fielding K; Greenwood M; Gibson J; Hertzberg M; Wright M; Lewis I; Moore J; Curtis D; Szer J; Kennedy G; Ritchie D, 2018, 'Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse', Internal Medicine Journal, 48, pp. 276 - 285, http://dx.doi.org/10.1111/imj.13522
2018
Ma CKK; García-Cadenas I; Fox ML; Ai S; Nivison-Smith I; Milliken ST; Dodds A; Fay K; Ma DDF; Martino R; Sierra J; Moore J, 2018, 'Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis', Bone Marrow Transplantation, 53, pp. 1478 - 1482, http://dx.doi.org/10.1038/s41409-018-0215-4
2018
Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA, 2018, 'CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry', International Journal of Laboratory Hematology, 40, pp. 533 - 539, http://dx.doi.org/10.1111/ijlh.12857
2018
Snowden JA; Badoglio M; Labopin M; Giebel S; McGrath E; Marjanovic Z; Burman J; Moore J; Rovira M; Wulffraat NM; Kazmi M; Greco R; Snarski E; Kozak T; Kirgizov K; Alexander T; Bader P; Saccardi R; Farge D, 2017, 'Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases', Blood Advances, 1, pp. 2742 - 2755, http://dx.doi.org/10.1182/bloodadvances.2017010041
2017
Bradstock KF; Link E; Iulio JD; Szer J; Marlton P; Wei AH; Enno A; Schwarer A; Lewis ID; D’Rozario J; Coyle L; Cull G; Campbell P; Leahy MF; Hahn U; Cannell P; Tiley C; Lowenthal RM; Moore J; Cartwright K; Cunningham I; Taper J; Grigg A; Roberts AW; Benson W; Hertzberg M; Deveridge S; Rowlings P; Mills AK; Gill D; Bardy P; Campbell L; Seymour JF, 2017, 'Idarubicin dose escalation during consolidation therapy for adult acute myeloid leukemia', Journal of Clinical Oncology, 35, pp. 1678 - 1685, http://dx.doi.org/10.1200/JCO.2016.70.6374
2017
Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Kwan J; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Gottlieb D; Kerridge I, 2017, 'Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?', Supportive Care in Cancer, 25, pp. 421 - 427, http://dx.doi.org/10.1007/s00520-016-3418-5
2017
Smith J; Poon C; Gilroy N; Kabir M; Brice L; Dyer G; Hogg M; Greenwood M; Moore J; Hertzberg M; Brown L; Tan J; Huang G; Kwan J; Larsen S; Ward C; Kerridge I, 2017, 'Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia', Supportive Care in Cancer, 25, pp. 137 - 144, http://dx.doi.org/10.1007/s00520-016-3398-5
2017
Lindsay J; Kabir M; Gilroy N; Dyer G; Brice L; Moore J; Greenwood M; Hertzberg M; Gottlieb D; Larsen SR; Hogg M; Brown L; Huang G; Tan J; Ward C; Kerridge I, 2016, 'Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia', Cancer Medicine, 5, pp. 3606 - 3614, http://dx.doi.org/10.1002/cam4.889
2016
Rebeiro P; Moore J, 2016, 'The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders', Internal Medicine Journal, 46, pp. 17 - 28, http://dx.doi.org/10.1111/imj.12944
2016
Gifford G; Gilroy N; Dyer G; Brice L; Kabir M; Greenwood M; Larsen S; Moore J; Gottlieb D; Hertzberg M; Kwan J; Huang G; Tan J; Brown L; Hogg M; Ward C; Kerridge I, 2016, 'The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia', Bone Marrow Transplantation, 51, pp. 1361 - 1368, http://dx.doi.org/10.1038/bmt.2016.135
2016
Dyer G; Larsen SR; Gilroy N; Brice L; Greenwood M; Hertzberg M; Kabir M; Brown L; Hogg M; Huang G; Moore J; Gottlieb D; Kwan J; Tan J; Ward C; Kerridge I, 2016, 'Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)', Cancer Medicine, 5, pp. 1702 - 1716, http://dx.doi.org/10.1002/cam4.729
2016
Oliveira MC; Labopin M; Henes J; Moore J; Papa ND; Cras A; Sakellari I; Schroers R; Scherer HU; Cuneo A; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Simões B; Snowden JA; Farge D, 2016, 'Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?', Bone Marrow Transplantation, 51, pp. 501 - 505, http://dx.doi.org/10.1038/bmt.2015.299
2016
Oliveira MC; Labopin M; Henes J; Moore J; Papa ND; Cras A; Sakellari I; Schroers R; Scherer HU; Cuneo A; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Simoes B; Snowden JA; Farge D, 2016, 'Erratum: Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? (Bone Marrow Transplantation (2016) 51 (501-505) DOI: 10.1038/bmt.2015.299)', Bone Marrow Transplantation, 51, pp. 889, http://dx.doi.org/10.1038/bmt.2016.126
2016
Dyer G; Gilroy N; Brown L; Hogg M; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Huang G; Tan J; Ward C; Kerridge I, 2016, 'What They Want: Inclusion of Blood and Marrow Transplanation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia', Biology of Blood and Marrow Transplantation, 22, pp. 731 - 743, http://dx.doi.org/10.1016/j.bbmt.2015.12.019
2016
Dyer G; Gilroy N; Bradford J; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I, 2016, 'A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia', British Journal of Haematology, 172, pp. 592 - 601, http://dx.doi.org/10.1111/bjh.13872
2016
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2016, 'Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial', The Lancet Oncology, 17, pp. 164 - 173, http://dx.doi.org/10.1016/S1470-2045(15)00462-3
2016
Snarski E; Snowden JA; Oliveira MC; Simoes B; Badoglio M; Carlson K; Burman J; Moore J; Rovira M; Clark RE; Saiz A; Hadj-Khelifa S; Tan J; Crescimanno A; Musso M; Martin T; Farge D, 2015, 'Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: A retrospective study of the EBMT autoimmune diseases working party (ADWP)', Bone Marrow Transplantation, 50, pp. 216 - 220, http://dx.doi.org/10.1038/bmt.2014.248
2015
Iland HJ; Collins M; Bradstock K; Supple S; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell L; Hugman A; Reynolds J; Di Lulio J; Campbell T; Taylor K; Filshie R; Seldon M; Tape J; Szer J; Moore JJ; Bashford J; Seymour JF, 2015, 'Impact of incorporating arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia: final analysis of th Australian Leukaemia and Lymphoma Group (ALLG) APML4 non-randomised phase II trial', Lancet (North American Edition), 9, pp. e357 - e366
2015
Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF, 2015, 'Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: A non-randomised phase 2 trial', The Lancet Haematology, 2, pp. e357 - e366, http://dx.doi.org/10.1016/S2352-3026(15)00115-5
2015
Kumarasinghe G; Lavee O; Parker A; Nivison-Smith I; Milliken S; Dodds A; Joseph J; Fay K; Ma DD; Malouf M; Plit M; Havryk A; Keogh AM; Hayward CS; Kotlyar E; Jabbour A; Glanville AR; Macdonald PS; Moore JJ, 2015, 'Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors', Journal of Heart and Lung Transplantation, 34, pp. 1406 - 1414, http://dx.doi.org/10.1016/j.healun.2015.05.021
2015
Shen S; Xu N; Klamer G; Ko KH; Khoo M; Ma D; Moore J; O'Brien TA; Dolnikov A, 2015, 'Small-molecule inhibitor of glycogen synthase kinase 3β 6-bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice', Stem Cells and Development, 24, pp. 724 - 736, http://dx.doi.org/10.1089/scd.2014.0230
2015
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2015, 'Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial', The Lancet Oncology, http://dx.doi.org/10.1016/S1470-2045(15)00462-3
2015
Alexander T; Bondanza A; Muraro PA; Greco R; Saccardi R; Daikeler T; Kazmi M; Hawkey C; Simoes BP; Leblanc K; Fibbe WE; Moore J; Snarski E; Martin T; Hiepe F; Velardi A; Toubert A; Snowden JA; Farge D, 2015, 'SCT for severe autoimmune diseases: Consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking', Bone Marrow Transplantation, 50, pp. 173 - 180, http://dx.doi.org/10.1038/bmt.2014.251
2015
Subramaniam K; Yeung D; Grimpen F; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2014, 'Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?', Internal Medicine Journal, 44, pp. 287 - 290, http://dx.doi.org/10.1111/imj.12363
2014
Bryant A; Nivison-Smith I; Pillai ES; Kennedy G; Kalff A; Ritchie D; George B; Hertzberg M; Patil S; Spencer A; Fay K; Cannell P; Berkahn L; Doocey R; Spearing R; Moore J, 2014, 'Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients', Bone Marrow Transplantation, 49, pp. 17 - 23, http://dx.doi.org/10.1038/bmt.2013.142
2014
Walker I; Schultz KR; Toze CL; Kerr HM; Moore J; Szwajcer D; Foley SR; Kuruvilla J; Panzarella T; Couture F; Roy J; Couban S; Devins G; Popradi G; Lee SJ; Tay J; Nevill TJ; Elemary M; Gallagher G, 2014, 'Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial', BLOOD, 124, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349242702187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Bilmon I; Nivison-Smith I; Hertzberg M; Ritchie D; Greenwood M; Spencer A; Kennedy G; Bryant A; Moore J, 2014, 'Outcomes following second allogeneic haematopoietic transplants using fludarabine–melphalan conditioning', Bone Marrow Transplantation, 49, pp. 852 - 853, http://dx.doi.org/10.1038/bmt.2014.23
2014
Khoo MLM; Carlin SM; Lutherborrow MA; Jayaswal V; Ma DDF; Moore JJ, 2014, 'Gene profiling reveals association between altered Wnt signaling and loss of T-cell potential with age in human hematopoietic stem cells', Aging Cell, 13, pp. 744 - 754, http://dx.doi.org/10.1111/acel.12229
2014
Snarski E; Snowden JA; Badoglio M; Carlson K; Burman J; Oliveira MC; Moore J; Tan J; Rovira M; Clark RE; Saiz A; Khelifa SH; Crescimanno A; Laing L; Musso M; Martin T; Farge D, 2013, 'Outcome Of Pregnancy After Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Autoimmune Diseases (AD): A Retrospective Study Of The EBMT Autoimmune Diseases Working Party (ADWP)', Blood, 122, pp. 4640 - 4640, http://dx.doi.org/10.1182/blood.v122.21.4640.4640
2013
Carlin SM; Ma DD; Moore JJ, 2013, 'T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists', Cytotherapy, 15, pp. 224 - 230, http://dx.doi.org/10.1016/j.jcyt.2012.10.014
2013
Subramaniam K; Grimpen F; Yeung D; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2013, 'Immunosuppressive agents and the risk of hepatosplenic gamma delta-T cell lymphoma (HSTCL): Is the risk increased by concomitant use of anti-TNFs?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28, pp. 95 - 96, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900203&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Zimmermann H; Choquet S; Moore J; Salles G; Morschhauser F; Lamy T; Jaccard A; Horst HA; Leithäuser M; Dührsen U; Reinke P; Lebranchu Y; Neuhaus R; Lehmkuhl H; Tarella C; Schlattmann P; Riess H; Leblond V; Trappe RU, 2013, 'Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial', Leukemia, 27, pp. 2102 - 2105, http://dx.doi.org/10.1038/leu.2013.110
2013
Morrissey CO; Chen SC-A; Sorrell TC; Milliken S; Bardy PG; Bradstock KF; Szer J; Halliday CL; Gilroy NM; Moore J; Schwarer AP; Guy S; Bajel A; Tramontana AR; Spelman T; Slavin MA, 2013, 'Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial', The Lancet Infectious Diseases, 13, pp. 519 - 528, http://dx.doi.org/10.1016/S1473-3099(13)70076-8
2013
Zimmermann H; Choquet S; Dierickx D; Dreyling MH; Moore J; Valentin A; Striefler JK; Riess H; Leblond V; Trappe RU, 2013, 'Early and late posttransplant lymphoproliferative disorder after lung transplantation-34 cases from the European PTLD network', Transplantation, 96, http://dx.doi.org/10.1097/TP.0b013e31829b0868
2013
Iland ; Bradstock K; Supple S; Catalano A; Collins M; Hertzberg M; Browett P; Grigg A; Firkin F; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore JJ; Bashford J; Seymour JF, 2012, 'All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)', Blood, 120, pp. 1570 - 1580, http://dx.doi.org/10.1182/blood-2012-02-410746
2012
Snowden JA; Saccardi R; Allez M; Ardizzone S; Arnold R; Cervera R; Denton C; Hawkey C; Labopin M; Mancardi G; Martin R; Moore JJ; Passweg J; Peters C; Rabusin M; Rovira M; Van Laar JM; Farge D, 2012, 'Haematopoietic SCT in severe autoimmune diseases: Updated guidelines of the European group for blood and marrow transplantation', Bone Marrow Transplantation, 47, pp. 770 - 790, http://dx.doi.org/10.1038/bmt.2011.185
2012
Snowden J; Saccardi R; Allez M; Ardizzone S; Arnold RH; Cervera R; Denton CP; Hawkey CJ; Labopin M; Mancardi GL; Martin RP; Moore JJ; Passweg J; Peters C; Rabusin M; Rovira M; Van Laar J; Farge D, 2012, 'Haematopoietic stem cell transplanation (HSCT) in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow transplatation (EBMT)', Bone Marrow Transplantation, 47, pp. 770 - 790
2012
Chih S; Mcdonald PS; Mccrohon JA; Ma DD; Moore JJ; Feneley MP; Law MG; Kovacic JC; Graham RM, 2012, 'Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: A placebo-controlled crossover trial.', Heart, 98, pp. 282 - 290, http://dx.doi.org/10.1136/heartjnl-2011-300751
2012
Moore J; Englert H; Furlong T; Poon T; Milliken S; Ma D, 2012, 'Auto-HSCT induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide', Bone Marrow Transplantation, 47, pp. 1486 - 1487, http://dx.doi.org/10.1038/bmt.2012.67
2012
Moore JJ; Englert H; Furlong TJ, 2012, 'Stem cell transplant induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide', Bone Marrow Transplantation, 47, pp. 1486 - 1487
2012
Carlin S; Khoo ML; Ma DD; Joseph JE, 2012, 'Notch Signalling Inhibits CD4 Expression during Initiation and Differentiation of Human T Cell Lineage', PLoS ONE, 7, pp. e45342, http://dx.doi.org/10.1371/journal.pone.0045342
2012
Mollee P; Tiley C; Cunningham I; Moore JJ; Prince M, 2012, 'A Phase II study of risk-adapted intravenous Melphalan in patiens with AL Amyloidosis', British Journal of Haematology, 157, pp. 766 - 769, http://dx.doi.org/10.1111/j.1365-2141.2012.09080.x
2012
Bryant AJ; Pillai E; Kennedy G; Kalff A; Ritchie D; George B; Hertzberg M; Patil SS; Spencer A; Fay K; Cannell P; Berkahn L; Doocey R; Spearling R; Nivison-Smith I; Moore J, 2011, 'A Retrospective Analysis of 344 Fludarabine Melphalan RIC Allogeneic Stem Cell Transplants for Myeloid and Lymphoid Malignancies In Australia and New Zealand 1998–2008,', Blood, 118, pp. 4143 - 4143, http://dx.doi.org/10.1182/blood.v118.21.4143.4143
2011
Mollee P; Tiley C; Cunningham I; Moore J; Prince M; Cannell P; Gibbons S; Tate J; Paul S; Gill DS, 2011, 'A Phase II Study of Risk-Adapted Intravenous Melphalan in Patients with AL Amyloidosis,', Blood, 118, pp. 3973 - 3973, http://dx.doi.org/10.1182/blood.v118.21.3973.3973
2011
Nivison-Smith I; Dodds AJ; Dunkley H; Ma DD; Moore JJ; Simpson M; Szer J; Bradstock KF, 2011, 'Increased activity and improved outcome in unrelatred donor haemopoietic stem cell transplants for acute myeloid leukaemia in Australia, 1992-2005', Internal Medicine Journal, 41, pp. 27 - 34, http://dx.doi.org/10.1111/j.1445-5994.2010.02262.x
2011
Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2010, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases', Haematologica, 95, pp. 284 - 292, http://dx.doi.org/10.3324/haematol.2009.013458
2010
Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Moore JJ; Kozak T; Kotter I; Marmont A; Gratwohl A; Saccardi R, 2010, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases', Haematologica, 95, pp. 284 - 292
2010
Sasson SC; Smith S; Seddiki N; Zaunders J; Bryant AJ; Koelsch KK; Weatherall CJ; Munier CM; McGinley C; Yeung J; Mulligan S; Moore JJ; Cooper DA; Milliken ST; Kelleher AD, 2010, 'IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers', Cytokine, 50, pp. 58 - 68, http://dx.doi.org/10.1016/j.cyto.2009.12.001
2010
Grimpen F; Yeung D; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2009, 'Hepatosplenic T cell lymphoma, immunosuppressive agents and biologicals: what are the risks?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A314 - A314, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Farge-Bancel D; Labopin M; Tyndall A; Fassas A; Mancardi G-L; Van Laar J; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2008, 'Autogreffe de cellules souches hématopoïétiques (ASH) au cours de la sclérodermie systémique : 10ans d’expérience du groupe de travail de l’EBMT-EULAR sur les maladies auto-immunes (MAI)', La Revue de Médecine Interne, 29, pp. S300 - S301, http://dx.doi.org/10.1016/j.revmed.2008.10.040
2008
Kovacic JC; Moore JJ; Herbert AD; Ma DD; Boehm M; Graham RM, 2008, 'Endothelial progenitor cells, angioblasts, and angiogenesis - Old terms reconsidered from a current perspective', Trends in Cardiovascular Medicine, 18, pp. 45 - 51, http://dx.doi.org/10.1016/j.tcm.2007.12.002
2008
Kovacic JC; Macdonald PS; Feneley MP; Muller DW; Freund J; Dodds AJ; Milliken ST; Tao H; Itescu S; Moore JJ; Ma DD; Graham RM, 2008, 'Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD 133(+) cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascul', American Heart Journal, 156, pp. 954 - 963, http://dx.doi.org/10.1016/j.ahj.2008.04.034
2008
Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2008, 'Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases', Blood, 112, pp. 164 - 164, http://dx.doi.org/10.1182/blood.v112.11.164.164
2008
Englert H; Kirkham S; Moore JJ; Poon T; Katelaris C; McGill N; Schrieber L; Manolios N, 2008, 'Autologous stem cell transplantation in diffuse scleroderma: impact on hand structure and function', Internal Medicine Journal, 38, pp. 692 - 696, http://dx.doi.org/10.1111/j.1445-5994.2007.01593.x
2008
Wong LY; Moore J; Hill D; Brenner P; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Custing's syndrome can precipitate diabetes but mask non-Hodgkin's lymphoma', Medical Journal of Australia, 188, pp. 262, http://dx.doi.org/10.5694/j.1326-5377.2008.tb01608.x
2008
Potter V; Moore J, 2008, 'Randomised trials of graft versus host disease prophylaxis in haemopoietic stem cell transplantation', Reviews on Recent Clinical Trials, 3, pp. 130 - 138, http://dx.doi.org/10.2174/157488708784223790
2008
Wong LY; Moore JJ; Hill D; Brenner PC; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Cushing`s syndrome can precipitate diabetes but mask non-Hodgkin`s lymphoma', Medical Journal of Australia, 188, pp. 262 - 262, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000255914800025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Kovacic JC; Macdonald P; Feneley MP; Muller DW; Ma D; Tao H; Freund J; Milliken S; Dodds A; Moore J; Itescu S; Graham RM, 2007, 'Abstract 2669: The Use of Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization: the GAIN I study', Circulation, 116, http://dx.doi.org/10.1161/circ.116.suppl_16.ii_591-d
2007
Bryant A; Moore JJ; Dodds AJ; Milliken ST; Fay K; Ma DD, 2007, 'Pneumonitis and renal toxicity with sirolimus based GVHD prophylaxis for RIC allogeneic', Haematologica - the Hematology Journal, 92, pp. 516 - 516, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247176901661&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2007
Kovacic JC; Ma DD; Tao H; Herbert AD; Moore JJ; Graham RM, 2007, 'Phenotypic characterization of CD133+cells suggests a potent hemangioblast population', Circulation Research, 101, pp. E55 - E56, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249155000025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2007
Moore JD; Baichi M; Toledo R; Sitrin M, 2007, 'Pseudomelanosis of jejunum and ileum', Gastrointestinal Endoscopy, 66, pp. 857 - 859, http://dx.doi.org/10.1016/j.gie.2007.01.030
2007
Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins P; Ma DD; Moore JJ; Simpson JM; Szer J, 2007, 'Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004', Biology of Blood and Marrow Transplantation, 13, pp. 905 - 912, http://dx.doi.org/10.1016/j.bbmt.2007.04.003
2007
Kovacic JC; Macdonald PS; Freund J; Rasko J; Allan RM; Fernandes VB; Ma DD; Moore JJ; Graham RM, 2007, 'Profound thrombocytopenia related to G-CSF', American Journal of Hematology, 82, pp. 229 - 230, http://dx.doi.org/10.1002/ajh.20787
2007
Moore JJ; Nivison-Smith I; Goh K; Ma DD; Bradstock KF; Szer J; Durrant S; Schwarer AP; Bardy P; Herrmann RP; Dodds AJ, 2007, 'Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia', Biology of Blood and Marrow Transplantation, 13, pp. 601 - 607, http://dx.doi.org/10.1016/j.bbmt.2007.01.073
2007
Brown DA; Moore JJ; Johnen H; Smeets TJ; Bauskin AR; Kuffner T; Weedon H; Milliken ST; Tak PP; Smith MD; Breit SN, 2007, 'Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis - A potential marker of erosive joint destruction', Arthritis Care & Research, 56, pp. 753 - 764, http://dx.doi.org/10.1002/art.22410
2007
Anandacoomarasamy A; Moore J; McGill N; Manolios N; Englert H, 2006, 'Resolution of skin fibrosis and joint contractures in aggressive diffuse systemic sclerosis using autologous stem cell transplantation', APLAR Journal of Rheumatology, 9, pp. 298 - 301, http://dx.doi.org/10.1111/j.1479-8077.2006.00218.x
2006
Bryant A; Moore J, 2006, 'Rituximab and its potential for the treatment of rheumatoid arthritis', Therapeutics and Clinical Risk Management, 2, pp. 207 - 212, http://dx.doi.org/10.2147/tcrm.2006.2.2.207
2006
Carlin S; Moore JJ; Zaunders J; Kelleher T; Ma DD, 2006, 'Generation in vitro of T lineage cells from human adult haematopoietic stem cells', Clinical Immunology, 119, pp. S160 - S160, http://dx.doi.org/10.1016/j.clim.2006.04.430
2006
Carlin S; Moore JJ; Zaunders J; Kelleher AD; Ma DD, 2006, 'T lineage differentiation in vitro of adult Haematopoietic Stem Cells', CYTOMETRY PART A, 69A, pp. 399 - 400, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237187700018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Al-mashaleh M; Bak H; Moore JJ; Manolios N; Englert H, 2006, 'Resolution of sclerodermatous myocarditis after autologous stem cell transplantation', Annals of the Rheumatic Diseases, 65, pp. 1247 - 1248, http://dx.doi.org/10.1136/ard.2005.048405
2006
Dodds AJ; Moore JJ; Goh K; Bradstock KF; Szer J; Nivison-Smith I; Ma DD, 2006, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic stem cell transplantation (SCT) for AML', Biology of Blood and Marrow Transplantation, 12, pp. 27 - 27, http://dx.doi.org/10.1016/j.bbmt.2005.11.084
2006
Bai L; Deng Y; Dodds AJ; Milliken ST; Moore JJ; Ma DD, 2006, 'A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogenic haemopoietic stem cell transplant recipients', European Journal of Haematology, 77, pp. 425 - 431, http://dx.doi.org/10.1111/j.1600-0609.2006.00729.x
2006
Pierson RN; Moore J; Merion RM; Azimzadeh AMI, 2006, 'ABO-incompatible lung transplantation', International Congress Series, 1292, pp. 63 - 69, http://dx.doi.org/10.1016/j.ics.2006.03.052
2006
Englert H; Katelaris C; McGill N; Schrieber L; Moore JJ, 2005, '`Grape-sultana` sign represents a favourable response to aggressive treatment of early diffuse systemic scleroderma', Internal Medicine Journal, 35, pp. 436 - 437, http://dx.doi.org/10.1111/j.1445-5994.2005.00849.x
2005
Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; Van Laar J; Farge D; Andolina M; Arnold RH; Carreras E; Finke J; Kotter I; Kozak T; Lisukov I; Lowenberg B; Marmont A; Moore JJ; Saccardi R; Snowden J; van den Hoogen F; Wulffraat N; Zhou X; Tyndall A, 2005, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, 35, pp. 869 - 879
2005
David S; Englert H; Furlong TM; Rainer SP; Moore JJ, 2005, 'Red cell fragmentation preceding a renal crisis in a patient with systemic sclerosis undergoing haematopoietic stem cell transplantation', Bone Marrow Transplantation, 35, pp. 629 - 630, http://dx.doi.org/10.1038/sj.bmt.1704832
2005
Johnston AJ; Dodds AJ; Ma DD; Milliken ST; Fay KC; Cunningham PH; Moore JJ, 2005, 'Cytomegalovirus Viraemia after Allogeneic Transplant: A Prospective Study of a Risk-Adapted Strategy in a Single Transplant Unit.', Blood, 106, pp. 5374 - 5374, http://dx.doi.org/10.1182/blood.v106.11.5374.5374
2005
Ma DDF; Kovacic JC; Dodds A; Tao H; McDonald P; Feneley MP; Muller DW; Fruend J; Milliken S; Moore J; Itescu S; Graham RM, 2005, 'Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.', Blood, 106, pp. 4215 - 4215, http://dx.doi.org/10.1182/blood.v106.11.4215.4215
2005
Ponchel F; Verburg R; Bingham SJ; Brown AK; Moore JJ; Protheroe A; Short K; Lawson C; Morgan AW; Quinn M; Buch M; Field SL; Maltby SL; Masurel A; Douglas SH; Straszynski L; Fearon U; Veale DJ; Patel P; McGonagle D; Snowden J; Markham AF; Ma DD; Van Laar J; Papadaki HA; Emery P; Isaacs JD, 2005, 'Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia', Arthritis Research and Therapy, 7, pp. 80 - 92
2005
Bai L; Deng Y-M; Dodds AJ; Milliken S; Moore J; Ma DDF, 2005, 'A SYBR Green - Based Real Time PCR Method for Detection of Haemopoietic Chimerism in Allogeneic Stem Cell Transplant Recipients.', Blood, 106, pp. 5222 - 5222, http://dx.doi.org/10.1182/blood.v106.11.5222.5222
2005
Bai L; Deng YM; Dodds AJ; Milliken ST; Moore JJ; Ma DD, 2005, 'A SYBR green-based real time PCR method for detection of haemopoietic chimerism in allogeneic stem cell transplant recipients', Blood, 106, pp. 389B - 389B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233426102324&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Dodds AJ; Ma DD; Milliken ST; Fay K; Cunningham PH; Moore JJ, 2005, 'Cytomegalovirus viraemia after allogeneic transplant: A prospective study of a risk-adapted strategy in a single transplant unit', Blood, 106, pp. 429B - 429B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233426102475&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Ma DD; Kovacic JC; Dodds AJ; Tao H; Mcdonald PS; Feneley MP; Muller DW; Fruend J; Milliken ST; Moore JJ; Itescu S; Graham RM, 2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, 106, pp. 134B - 134B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233426100514&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Bingham S; Moore JJ, 2004, 'Rheumatoid arthritis', Best Practice and Research Clinical Haematology, 17, pp. 263 - 276, http://dx.doi.org/10.1016/j.beha.2004.05.002
2004
Moore JJ; Bradstock K; Dodds AJ; Szer J; Smith I; Goh KE; Ma DD, 2004, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic transplantation for AML', Blood, 104, pp. 378B - 378B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000225127701499&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2004
Moore JJ; Ma DD; Dodds T; Milliken ST; Fay K; Concannon A; smith I, 2004, 'Improved disease survival without increased GVHD using low dose cyclosporine and prednisone in allogeneic stem cell transplantation - A case control study', Blood, 104, pp. 371B - 371B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000225127701474&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2004
Moore JJ; Johnston AM; David M; Sam MJ; Keith F; Tony D, 2004, 'Treatment of steroid-refractory acute graft versus host disease with low dose combination monoclonal antibody therapy: A pilot study', Blood, 104, pp. 354A - 354A
2004
Zaunders JJ; Dyer WB; Wang B; Munier ML; Miranda-Saksena M; Newton R; Moore J; Mackay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection', Blood, 103, pp. 2238 - 2247, http://dx.doi.org/10.1182/blood-2003-08-2765
2004
Moore JJ; Ma DD; Will R; Cannell P; Handel ML; Milliken ST, 2004, 'A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation', Bone Marrow Transplantation, 34, pp. 241 - 247, http://dx.doi.org/10.1038/sj.bmt.1704570
2004
Snowden J; Passweg J; Moore JJ; Milliken ST; Cannell P; Van Laar J; Verburg R; Szer J; Taylor KM; Joske D; Rule S; Bingham S; Emery P; Burt R; Lowenthal RM; Durez P; McKendry R; Pavletic S; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks PM; Bredeson C; Tyndall A, 2004, 'Autologous hemopoietic stem cell transplantation in severe rheumatoidarthritis: A report from the EBMT and ABMTR', Journal of Rheumatology, 31, pp. 482 - 488
2004
Zaunders J; Dyer W; Wang B; Munier M; Miranda-Saksena M; Newton R; Moore JJ; MacKay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection', Blood, 8, pp. 2765 - 2765
2004
Brooks P; Moore JJ; Tyndall A, 2003, 'Stem cell transplantation in rheumatic diseases', Journal of Rheumatology, 6, pp. 79 - 82
2003
Moore JJ; Milliken ST; Ma DD; Biggs JC, 2003, 'Letter to the Editor CD34 selected versus unmanipulated grafts for severe rheumatoid arthritis: Reply', Arthritis Care & Research, 48, pp. 1464 - 1466
2003
Ponchel F; Papadaki H; Bingham S; Verburg R; Moore JJ; Protheroe A; McGonagle D; Snowden J; Van-Laar J; Markham A; Emery P; Isaacs D, 2003, 'Il-7 and therapy-induced lymphopenia in RA', Annals of the Rheumatic Diseases, 62, pp. 164 - 164
2003
Moore JJ; Snowden J; Pavletic S; Barr W; Burt R, 2003, 'Hematopoietic stem cell transplantation for severe rheumatoid arthritis', Bone Marrow Transplantation, 32, pp. 53 - 56, http://dx.doi.org/10.1038/sj.bmt.1703944
2003
Van Laar JM; Pavletic SZ; Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: Comment on the article by Moore et al [4] (multiple letters)', Arthritis and Rheumatism, 48, pp. 1463 - 1464, http://dx.doi.org/10.1002/art.10982
2003
Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: comment on the article by Moore et al - Reply', ARTHRITIS AND RHEUMATISM, 48, pp. 1464 - 1466, http://dx.doi.org/10.1002/art.11071
2003
Brooks P; Moore JJ; Tyndall A, 2002, 'A stem cell transplantation and gene therapy in Rheumatoid diseases', Annals of the Rheumatic Diseases
2002
Moore JJ; Brooks P; Milliken ST; Biggs JC; Ma DD; Handel ML; Will R; Rule S; Joske D; Langlands B; Taylor K; O Callaghan J; Szer J; Wicks I; McColl GJ; Passeullo F; Snowden J, 2002, 'A pilot randomised trial comparing CD34 selected versus unmanipulated haemopoietic stem cell transplanation for severe resistant rheumatoid arthritis', Arthritis Care & Research, 46, pp. 2301 - 2309, http://dx.doi.org/10.1002/art.10495
2002
Moore J; Brooks P, 2001, 'Stem cell transplantation for autoimmune diseases', Springer Seminars in Immunopathology, 23, pp. 193 - 213, http://dx.doi.org/10.1007/s002810100059
2001
Moore JJ; Milliken ST; Ma DD; Briggs JW; Brooks P, 2001, 'Peripheral blood stem cell transplantation for rheumatoid arthritis - Australian experience', Journal of Rheumatology, 28, pp. 8 - 12
2001
Moore JJ; Tyndall A; Brooks P, 2001, 'Stem cells in the aetiopathogenisis and therapy of rheumatic disease.', Best Practice and Research in Clinical Rheumatology, 15, pp. 711 - 726
2001
Solomon B; Moore JJ; Arthur C; Prince HM, 2001, 'Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: A multicentre randomised comparison of urokinase versus heparin', European Journal of Cancer, pp. 2379 - 2384
2001
Moore JJ; Brooks P, 2001, 'Haemopoietic stem cell transplantation', Springer Seminars in Immunopathology, pp. 193 - 213
2001
Moore J; Aboud M; Ma D, 2000, 'Adult transient lupus anticoagulant patients maintain an acquired activated protein C resistance profile', Thrombosis and Haemostasis, 84, pp. 735 - 736, http://dx.doi.org/10.1055/s-0037-1614103
2000
Moore J; Coyle L; Isbister J; Roche J, 1999, 'Bilateral knee osteonecrosis in a patient with thrombotic thrombocytopenic purpura', Australian and New Zealand Journal of Medicine, 29, pp. 88 - 89, http://dx.doi.org/10.1111/j.1445-5994.1999.tb01596.x
1999
Moore J; Ma DD; Concannon A, 1998, 'Non-malignant bone marrow necrosis: a report of two cases.', Pathology, 30, pp. 318 - 320, http://dx.doi.org/10.1080/00313029800169536
1998
Moore J; Ma DDF; Concannon A, 1998, 'Non-malignant bone marrow necrosis: A report of two cases', Pathology, 30, pp. 316 - 318, http://dx.doi.org/10.1080/00313029800169526
1998
Moore JJ; Isbister JP; Clifton-Bligh P; Eckstein RP, 1998, 'Calcitriol mediated hypercalcaemia in a T cell rich B cell lymphoma [10]', Australian and New Zealand Journal of Medicine, 28, pp. 479 - 480, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02091.x
1998
Conference Abstracts
add
Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'A minority of women of child bearing potential are tested for pregnancy before chemoimmunotherapy: An Australian Cancer Centre Experience', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 209 - 210, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500352&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rogers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'Rates of sexual history taking and sexual dysfunction counselling with cancer care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 175 - 176, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500278&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'Rates of contraceptive uptake and documentation of discussion with anticancer therapy: Women deserve gender specific care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 209 - 209, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500351&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'Rates of fertility discussions and counselling before, during and after anticancer treatments: Women deserve gender specific care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 175 - 175, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500277&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; Moore J; McCaughan G; Hamad N; Hurwitz J, 2022, 'Rate of menstruation history taking and counselling before, during and after anticancer treatments', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 174 - 175, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500276&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Penglase R; Brenu E; Englert H; Milliken S; Withers B; Karki N; Perram J; Tao H; Girgis L; Jabbour A; Kotlyar E; Ma D; Moore J, 2022, 'NT-proBNP measurements during cyclophosphamide conditioning in patients undergoing autologous haemopoietic stem cell transplantation for systemic sclerosis suggest increased cardiac strain', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, CZECH REPUBLIC, Vol. 57, pp. 128 - 128, presented at 48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), CZECH REPUBLIC, 19 March 2022 - 23 March 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000878153300192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Moore J; Penglase R; Englert H; Milliken S; Withers B; Karki N; Perram J; Tao H; Jabbour A; Kotylar E; Ma D, 2022, 'Low dose cyclophosphamide conditioning is safe in systemic sclerosis patients ineligible for standard dose regimens - an interim analysis of the prospective assure trial', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, CZECH REPUBLIC, Vol. 57, pp. 25 - 25, presented at 48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), CZECH REPUBLIC, 19 March 2022 - 23 March 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000878153300039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Perram J; Hamad N; Moore J, 2022, 'Low rates of testing and high prevalence of vitamin d deficiency before and after transplantation at an australian transplant centre', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, CZECH REPUBLIC, Vol. 57, pp. 353 - 354, presented at 48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), CZECH REPUBLIC, 19 March 2022 - 23 March 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000878153300570&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Massey J; Jackson K; Singh M; Hughes B; Ford C; Zaunders J; Charmeteau-De-Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2021, 'Haematopoietic stem cell transplantation for multiple sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Vol. 27, pp. 349 - 349, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000706771301178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Sharrack B; Saccardi R; Alexander T; Manuela B; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro P; Rovira M; Sormani MP; Snowden J, 2020, 'Autologous haematopoietic stem cell transplantation in multiple sclerosis and other immune-mediated neurological diseases: guidelines and recommendations of the European Society for Blood and Marrow Transplantation and the Joint Accreditation Committee of the International Society for Cellular Therapy', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058007199&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Saccardi R; Badoglio M; Burman J; Helbig G; Innocenti C; Kazmi M; Mancardi GL; Moore J; Muraro P; Sharrack B; Smilowski M; Sormani MP; Snowden JA, 2020, 'Beam vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, Vol. 55, pp. 37 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000600556200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Hendrawan K; Ford C; Khoo M; Zaunders J; Molloy T; Ma D; Moore J, 2019, 'CD39+T regulatory cell reconstitution in MS patients with different CD39 gene polymorphisms undergoing autologous HSCT: A Preliminary Study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, Vol. 26, pp. NP18 - NP18, presented at Conference of MS-Research-Australia, AUSTRALIA, Melbourne, 31 October 2019 - 01 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524556200062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Ford C; Khoo M; Zaunders J; Hendrawan K; Massey J; Sutton I; Milliken S; Ma D; Moore JJ, 2017, 'Identification of the immune phenotypes associated with haematopoietic stem cell transplantation for Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, Vol. 23, pp. NP23 - NP23, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Lindsay J; Kabir M; Gilroy N; Dyer G; Brice L; Greenwood M; Moore J; Hertzberg M; Larsen S; Kwan J; Brown L; Hogg M; Huang G; Tan J; Gifford G; Kerridge I, 2016, 'Complementary and Alternative Medicine Therapy (CAM) Use by Allogeneic BMT Survivorship Patients', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, Honolulu, HI, Vol. 22, pp. S476 - S476, presented at BMT Tandem Meetings, Honolulu, HI, 18 February 2016 - 22 February 2016, http://dx.doi.org/10.1016/j.bbmt.2015.11.1091
2016
Book Chapters
add
Penglase R; Sandler RD; Moore J; Snowden JA, 2021, 'Hematopoietic Stem Cell Transplantation for Rheumatoid Arthritis', in Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases, CRC Press, pp. 547 - 556, http://dx.doi.org/10.1201/9781315151366-58
2021
Conference Papers
add
Cashman H; Hamad N; Moore J; Milliken S; Lavee O; Withers B; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S, 2019, 'An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-127796
2019
Hardefeldt P; Moore J; Milliken S; Fay K; Orly L; Mayson E; Withers B; Hamad N, 2019, 'Dose Adjusted R-EPOCH Does Not Improve Outcomes in High Grade B Cell Lymphoma with Double Expressor Status or Gain of MYC/BCL2', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-125154
2019
Fleming S; Venn N; Reynolds J; Nguyen U; Kwan J; Moore J; Yeung DT; Leahy MF; Greenwood M; Verner E; Bajel A; Berkahn L; Wei AH; Sutton R, 2019, 'Preliminary Minimal Residual Disease Analysis of the Australasian Leukaemia & Lymphoma Group (ALLG) ALL8 Study of Front-Line Blinatumomab with Chemotherapy in Adults with Ph Negative B-Cell Acute Lymphoblastic Leukaemia', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-132048
2019
Ford CD; Khoo M; Zaunders J; Massey J; Hendrawan K; Sutton I; Ma DDF; Moore JJ, 2018, 'Analysis of Immune Reconstitution by Multicolour Flow Cytometry in Multiple Sclerosis and Non-Autoimmune Patients Following Autologous Haematopoietic Stem Cell Transplantation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, PORTUGAL, Lisbon, pp. 203 - 203, presented at 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), PORTUGAL, Lisbon, 18 March 2018 - 21 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487702802073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Kenneth B; Link E; Di Iulio J; Szer J; Marlton P; Wei A; Enno A; Schwarer AP; Lewis ID; D'Rozario J; Coyle L; Cull G; Campbell P; Leahy MF; Hahn UH; Cannell P; Tiley C; Lowenthal RM; Moore J; Cartwright K; Cunningham I; Taper J; Grigg A; Roberts AW; Benson WJ; Hertzberg MS; Deveridge SF; Rowlings PA; Mills AK; Gill DS; Bardy PG; Campbell L; Seymour JF, 2016, 'Increased Idarubicin Dosage during Consolidation Therapy for Adult Acute Myeloid Leukemia Improves Leukemia-Free Survival', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), CA, San Diego, 03 December 2016 - 06 December 2016, http://dx.doi.org/10.1182/blood.V128.22.338.338
2016
Kumarasinghe G; Lavee O; Nivison-Smith I; Parker A; Malouf M; Keogh A; Milliken S; Dodds A; Plit M; Hayward C; Ma D; Fay K; Joseph J; Kotlyar E; Havryk A; Jabbour A; Glanville A; Macdonald P; Moore J, 2014, 'Defining Prognostic Markers in Heart and Lung Transplant Recipients with PTLD', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CA, San Diego, pp. S84 - S84, presented at 34th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, CA, San Diego, 10 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/j.healun.2014.01.260
2014
Oliveira MC; Labopin M; Henes J; Moore J; Del Papa N; Stanciu R; Sakellari I; Schroers R; Scherer HU; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Snowden JA; Farge D, 2014, 'Does Ex Vivo CD34+Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, presented at 56th Annual Meeting of the American-Society-of-Hematology, CA, San Francisco, 06 December 2014 - 09 December 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349243502176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Lim ABM; Curley C; Fong CY; Bilmon I; Beligaswatte A; Purtill D; Getta B; Johnston AM; Armytage T; Collins M; Mason K; Fielding K; Greenwood M; Gibson J; Hertzberg M; Wright M; Lewis I; Moore J; Curtis D; Szer J; Kennedy G; Ritchie DS, 2014, 'The Australian Experience with Relapsed Acute Myeloid Leukaemia Post Allogeneic Haematopoietic Stem Cell Transplantation Yields a Simple Prognostic Index for Survival after Relapse', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, TX, Grapevine, pp. S38 - S39, presented at BMT Tandem Meetings, TX, Grapevine, 26 February 2014 - 02 March 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331155400030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Kumarasinghe G; Lavee O; Parker A; Keogh A; Hayward C; Kotlyar E; Jabbour A; Havryk A; Malouf M; Plit M; Glanville A; Macdonald P; Moore J, 2013, 'Risk Factors and Response to Therapy in Heart and Lung Transplant Recipients with Post-Transplant Lymphoproliferative Disease', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CANADA, Montreal, pp. S254 - S254, presented at 33rd Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, CANADA, Montreal, 24 April 2013 - 27 April 2013, http://dx.doi.org/10.1016/j.healun.2013.01.657
2013
Ibrahim K; Moore J; Horne A, 2013, 'Successful Stem Cell Mobilisation with Plerixafor in a Patient with Multiple Myeloma and Dialysis-Dependant Renal Failure', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, UT, Salt Lake City, pp. S184 - S184, presented at BMT Tandem Meetings, UT, Salt Lake City, 13 February 2013 - 17 February 2013, http://dx.doi.org/10.1016/j.bbmt.2012.11.179
2013
Khoo M; Carlin S; Lutherborrow M; Ma D; Moore J, 2013, 'GENE ARRAY ANALYSIS OF HUMAN HEMATOPOIETIC STEM CELLS REVEALS ASSOCIATION BETWEEN AGE, ALTERED SIGNALING AND LOSS OF LYMPHOCYTE POTENTIAL', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRIA, Vienna, pp. S33 - S33, presented at 42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH), AUSTRIA, Vienna, 22 August 2013 - 25 August 2013, http://dx.doi.org/10.1016/j.exphem.2013.05.130
2013
Kovacic JC; Macdonald P; Feneley MP; Muller DW; Ma D; Tao H; Freund J; Milliken S; Dodds A; Moore J; Itescu S; Graham RM, 2007, 'The use of granulocyte-colony stimulating factor in angina patients to stimulate neovascularization: the GAIN I study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, FL, Orlando, pp. 591 - 592, presented at 80th Annual Scientific Session of the American-Heart-Association, FL, Orlando, 04 November 2007 - 07 November 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250394302670&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2007
Kovacic JC; Macdonald PS; Feneley MP; Muller DW; Ma DD; Tao H; Freund J; Milliken ST; Dodds AJ; Moore JJ; Itescu S; Graham RM, 2007, 'The use of granulocyte-colony stimulating factor in angina patients to stimulate neovascularization: the GAIN I study', in Circulation, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 2669 - 2670, presented at 80th Annual Scientific Session of the American-Heart-Association, Orlando, Florida, USA, 04 November 2007 - 07 November 2007
2007
Other
add
Dyer G; Gilroy N; Brown L; Hogg M; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Huang G; Tan J; Ward C; Kerridge I, 2016, Erratum: Erratum to: “What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia” (Biol Blood Marrow Transplant (2016) 22 (731–743)), , http://dx.doi.org/10.1016/j.bbmt.2016.04.023
2016
Reports
add
Bhattacharyya A; Sahhar J; Milliken S; Ma D; Englert H; Tymms K; Danta M; Moore J, 2015, Autologous hematopoietic stem cell transplant for systemic sclerosis improves anemia from gastric antral vascular ectasia, http://dx.doi.org/10.3899/jrheum.141234
2015
Preprints
add
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee S; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, Anti-Thymocyte Globulin for Patients Undergoing Hematopoietic Cell Transplantation from Unrelated Donors: A Randomized, Controlled, Open-Label, Phase 3, Multicentre Trial from Cell Therapy Transplant Canada, , http://dx.doi.org/10.2139/ssrn.3429920